Ground Swell Capital LLC Invests $1.60 Million in VanEck Pharmaceutical ETF $PPH

Posted by Michael Walen on Jun 27th, 2026

Ground Swell Capital LLC bought a new stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund bought 15,445 shares of the company’s stock, valued at approximately $1,604,000. VanEck Pharmaceutical ETF accounts for approximately 3.2% of Ground Swell Capital LLC’s holdings, making the stock its 3rd largest holding.

Several other large investors have also recently made changes to their positions in PPH. IMC Chicago LLC acquired a new stake in VanEck Pharmaceutical ETF during the fourth quarter valued at $1,707,000. Tudor Investment Corp ET AL purchased a new position in VanEck Pharmaceutical ETF in the third quarter valued at $678,000. Cherry Creek Investment Advisors Inc. acquired a new position in shares of VanEck Pharmaceutical ETF in the fourth quarter worth about $1,355,000. Integrity Alliance LLC. acquired a new position in shares of VanEck Pharmaceutical ETF in the fourth quarter worth about $526,000. Finally, Leuthold Group LLC purchased a new stake in shares of VanEck Pharmaceutical ETF during the 4th quarter worth about $906,000.

VanEck Pharmaceutical ETF Stock Up 2.5%

NASDAQ:PPH opened at $109.44 on Friday. VanEck Pharmaceutical ETF has a 52 week low of $81.74 and a 52 week high of $112.58. The stock has a market capitalization of $1.04 billion, a PE ratio of 20.21 and a beta of 0.47. The stock’s 50-day moving average price is $103.24 and its 200-day moving average price is $104.61.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 7th. Shareholders of record on Wednesday, April 1st were given a dividend of $0.8441 per share. This is an increase from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31. This represents a $3.38 dividend on an annualized basis and a yield of 3.1%. The ex-dividend date was Wednesday, April 1st.

VanEck Pharmaceutical ETF Profile

(Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.